News Center

Home page

Peak Report

News reports

Sales of summer heat prevention drugs in large pharmacies increased significantly

Release time:

2022-08-24

News from our newspaper # The high temperature continued after February, which is the peak season for sales of heatstroke prevention and cooling drugs. Peak pharmacies seized the opportunity to actively expand group buying customers, with significant year-on-year growth in the number of customers and sales.

Since the new crown epidemic, store epidemic prevention requirements are strict, customers need to enter the store multiple steps, coupled with four categories of drug sales restrictions, retail pharmacy business has generally been affected. In the face of difficulties, Jianfeng Pharmacy has actively explored its ideas and looked for sales growth points. From July , it has carefully selected the categories of heatstroke prevention drugs and has planned stock to ensure sufficient supply of goods and drugs in summer, so as to purchase a variety of varieties and varieties. Each category is equipped with multiple manufacturers, high, medium and low prices, for different customers to choose according to their respective situations.

The summer weather this year was sultry. There was no continuous precipitation after entering the plum. The high temperature weather started early and lasted for a long time. The heatstroke prevention and cooling drugs were popular. Jianfeng Pharmacy maintains old customers and develops new customers. Actively contact customers with more outdoor operations such as logistics and construction and more high-temperature workers; Actively participate in the bidding for heatstroke prevention drugs and group buying products. Fang Yanfei, manager of Shuangxi Store, who is responsible for contacting customers, said that the sales are mainly small group purchases, with a relatively small total amount and a large number of customers. According to the working characteristics and budget of different customers, drug combinations with different prices have been prepared. Each drug has been compared with other merchants in advance to set a reasonable price and improve the success rate of group purchases. In summer, many pharmacies are competing for the group purchase business of heatstroke prevention drugs. Some customers communicated four or five times and discussed it for a long time. Through hard work, the number of customers of group purchase of heatstroke prevention drugs increased from

11 in the same period last year to 20 enterprises and institutions, with sales increasing by 209% year on year.

After the group purchase is negotiated, the business department will quickly transfer the goods according to the customer's demand to ensure timely supply. Among the heatstroke prevention drugs, liquid drugs such as Huoxiang Zhengqi water account for a large proportion. When delivery, customers have to be moved into warehouses, and some have to be transported upstairs. Most pharmacies are female employees, but everyone still overcomes difficulties and provides customers with the best quality. service. In addition to the group buying business, each store also has a variety of products for customers to buy in the store.

Summer heatstroke prevention drug group purchase has increased, but it belongs to seasonal sales, the total amount is relatively small, and the gross profit of some drugs is low. In the future, the peak pharmacy will adjust its sales focus in due course, strengthen the sales of tonic drugs in autumn and winter, and intensify its efforts to build a famous doctor of traditional Chinese medicine. Continuously improve the product structure, implement

"one product with multiple regulations" in each store, and implement multi-manufacturer, multi-grade and multi-specification matching to promote sales of products with large sales volume; We should dig new growth points from multiple angles and seek ways to "break the game. (Reporter

Chen Shengmu)

More information

Two Cement Enterprises Prosperous Production and Sales in May

With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.

2020

07-31

The company's "safe production month" activities are about to start

June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.

2020

07-31

Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua

News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.

2020

07-31

Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua

2020

07-30

Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua

2020

07-22

The 14th meeting of the 10th board of directors and the 9th meeting of the 9th board of supervisors held to review and approve the annual work report and other relevant proposals

On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.

2020

07-31

< 1...23 24 25...61 > 跳转到页